Original article
Use of recombinant human interferon gamma to enhance neutrophil chemotactic responses in Job syndrome of hyperimmunoglobulinemia E and recurrent infections*

https://doi.org/10.1016/S0022-3476(05)82151-1Get rights and content

Recombinant human interferon gamma enhances neutrophil respiratory burst and bactericidal activity in patients with chronic granulomatous disease. Mononuclear leukocytes of patients with the hyperimmunoglobulinemia E syndrome (Job syndrome) produce low or undetectable levels of this lymphokine. For these reasons we have restudied neutrophil chemotaxis in a group of our patients with the syndrome and determined the effect of recombinant human interferon gamma on the responses. Each of the patients had neutrophil chemotactic responses ranging from 22% to 55% of simultaneous control values (p<0.001). After incubation with interferon gamma, a significant improvement in chemotactic responsiveness was observed in the neutrophils of each of the patients (mean 301% of baseline chemotaxis; p<0.008). These data suggest the need for a double-blind, placebo-controlled trial of interferon gamma in a larger group of patients with the syndrome of hyperimmunoglobulinemia E and recurrent infections.

References (22)

  • EzekowitzRAB et al.

    Partial correction of the phagocytic defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma

    N Engl J Med

    (1988)
  • Cited by (59)

    • STAT3 mutation-associated airway epithelial defects in Job syndrome

      2023, Journal of Allergy and Clinical Immunology
    • Immunomodulators

      2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
    • Disorders of Leukocyte Function

      2013, Emery and Rimoin's Principles and Practice of Medical Genetics
    • Infectious Complications of Dysfunction or Deficiency of Polymorphonuclear and Mononuclear Phagocytes

      2012, Principles and Practice of Pediatric Infectious Diseases, Fourth Edition
    • Host Defense Mechanisms Against Bacteria

      2011, Fetal and Neonatal Physiology E-Book, Fourth Edition
    View all citing articles on Scopus
    *

    Supported by U.S. Public Health Service grants AI 13150 and AI19094, National Institute of Allergy and Infectious Diseases, and by Genentech, Inc.

    Presented in part at the Annual Meeting of the Society for Pediatric Research, Washington, D.C., May 1989, and published in abstract form (Pediatr Res 1989; 25:164A).

    View full text